[Regional immunocorrective therapy using laferon in patients with suppurative cholangitis].
In patients with purulent cholangitis after correction of major bile outflow, intracholedochal administration of laferon was used together with general and antibacterial therapy. This contributed to improvement in the function of a cellular link of immunity, decrease in intensity of autoimmune response of the own lymphocytes, stabilization of general inflammatory response of the organism which resulted in normalization of pathologically increased laboratory and biochemical indices in the blood analyses of the patients.
Nichitaĭlo
M E
ME
D002761:Cholangitis / Q000188:drug therapy* / Q000276:immunology; D005704:Gallbladder; D006801:Humans; D007111:Immunity, Cellular; D007370:Interferon Type I / Q000008:administration & dosage*; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D008214:Lymphocytes / Q000276:immunology; D011994:Recombinant Proteins; D013492:Suppuration
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Regionarnaia immunokorrigiruiushchaia terapiia s primeneniem laferona u bol'nykh s gnoĭnym kholangitom.